SCHEMBL31704847

SCHEMBL31704847

COC(=O)c1cnc(C2=CCNCC2)s1.COC(=O)c1cnc(C2=CCNCC2)s1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 1/20 0.37
▸ CCNT1 O60563 7/20 0.36
▸ CDK9 P50750 7/20 0.36
▸ QDPR P09417 2/20 0.36
▸ CDC7 O00311 1/20 0.36
▸ DBF4 Q9UBU7 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.35
▸ WNT3A P56704 2/20 0.35
▸ NAMPT P43490 1/20 0.34
▸ RGS12 O14924 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ GABRR1 P24046 1/20 0.34
▸ GABRR2 P28476 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ GNAI1 P63096 1/20 0.34
▸ PMP22 Q01453 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31706252 1.00 CRBN (0.37) CRBNCCNT1CDK9QDPRCDC7
SCHEMBL24671284 0.84 MAPK1 (0.39) CCNT1CDK9QDPRHRH3NAMPT
SCHEMBL24669890 0.82 ULK1 (0.37) CCNT1CDK9QDPRHRH3WNT3A
SCHEMBL24671230 0.77 NAMPT (0.51) CCNT1CDK9QDPRWNT3ANAMPT
SCHEMBL15001490 0.74 HRH3 (0.42) QDPRHRH3
SCHEMBL31706060 0.74 MAOA (0.46) CRBNQDPRRGS12CYP3A4TSHR
SCHEMBL31704793 0.74 MAOA (0.46) CRBNQDPRRGS12CYP3A4TSHR
SCHEMBL24669893 0.73 SLC6A3 (0.43) WNT3ANAMPT
SCHEMBL63723 0.72 WNT3A (0.39) CCNT1CDK9QDPRHRH3WNT3A
SCHEMBL31705952 0.72 QDPR (0.45) QDPRWNT3ANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215110-A1 NEW AMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS SOS1 INHIBITORS LES LABORATOIRES SERVIER (FR) 2025-10-16 — — WO disclosed
Send feedback